Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel,with or without trastuzumab as adjuvant therapy in node-positive。PTEN activation contributes to tumor inhibition by trastuzumab,and l ......